Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and adult toys.
Popular Articles

Surgeon General Releases Call To Action To Promote Healthy Homes
Statement of Charles D. Connor, American Lung Association President and CEO:
buy viagra
Men Lack Sympathy For Rape Victims
Men blame male victims of rape for not fighting off their attacker. This is one of the findings of Dr Michelle Davies and Dr Paul Rogers from University of Central Lancashire who will present their research at the British Psychological Society"s Division of Forensic Psychology Annual Conference today, Wednesday 24th June 2009. The conference is being held the University of Central Lancashire, Preston.
News of the day
Study Shows Decreased Risk Of Death From Opportunistic Infections With Earlier Antiretroviral Treatment
HIV-positive people with opportunistic infections who receive earlier antiretroviral treatment lower their risk of death compared with people who delay treatment, according to a new study conducted by the Stanford University School of Medicine and published in PLoS One, the San Jose Mercury News reports. The findings could lead to changes in recommendations for antiretroviral treatment protocol, specifically for patients diagnosed with HIV at an advanced stage, the Mercury News reports. The study included 262 HIV-positive participants at 39 health care sites across the U.S., and 20 participants in South Africa. During the yearlong study, the researchers found that among the participants who were treated promptly after developing an opportunistic infection, 14% died or developed another infection. The researchers also found that 24% of participants who deferred treatment for an average of 45 days died or had a decrease in health outcomes. According to the Mercury News, the question of when to start HIV-positive people on antiretroviral treatment remains unclear because of issues such as the high cost of medicines, side effects, and drug interactions or resistance. Andrew Zolopa, head of Stanford University School of Medicine"s division of infectious diseases and lead investigator of the study, said that physicians often treat HIV-positive people for an "acute crisis, then follow up later with treatment for HIV." He continues, "But that answer is wrong. The study shows very clearly that there is no safety downside to doing this -- and the benefit is quite substantial, reducing death by 50%." "Even in San Francisco, one of the first epicenters of HIV in the United States, we still find that many people present late in the course of their illness with an opportunistic infection," Mitch Katz, director of San Francisco"s Department of Health who was not involved in the study, said. He added, "This study shows that it is lifesaving to treat those persons with antiretroviral drugs while they are still in the hospital." Katz said that the results could lead to changes in HIV/AIDS practices worldwide. The International AIDS Society, CDC and the British AIDS Society have developed guidelines recommending that early antiretroviral treatment be considered in patients with opportunistic infections, Zolopa said. In addition, NIH is considering an international study to examine earlier initiation of antiretroviral treatment involving more than 9,000 people from both developed and developing countries (Krieger, San Jose Mercury News, 5/15).
Oncology

Heart Age Could Help Revolutionise CVD Risk Management

Unilever and the World Heart Federation announce a joint initiative to promote awareness of Heart Age - a new, personally motivating way of expressing an individual"s risk of developing heart disease and stroke. At a global media launch, leading worldwide cardiovascular disease (CVD) experts - including Professor Pekka Puska (President, World Heart Federation) and Professor Rod Jackson (Head of Clinical Epidemiology & Biostatistics, University of Auckland) - pledged their support for the new concept, which they believe could help in the global effort to reduce CVD, the leading cause of premature death worldwide. Heart Age, based on the well-established and highly respected Framingham Risk Score, uses standard risk factors for heart disease or stroke (such as age, weight, gender, cholesterol, blood pressure and smoking) to estimate a person"s "Heart Age", which could be higher than their chronological age if their personal CVD risk factors are high. Today"s gathering supports the fact that this could be a powerful way for health professionals to help motivate people, at all levels of risk, to make the behavioural changes needed to keep their hearts healthier for longer. Professor Puska stated: "If Heart Age can engage individuals and motivate them to change their diet and lifestyle for the better, no matter what their level of risk, then this could be a breakthrough in the global effort towards improved CVD prevention, saving hundreds of thousands of lives and sparing many more the misery of heart disease and stroke." Professor Rod Jackson, Head of Epidemiology & Biostatistics at the University of Auckland"s School of Population Health, commented: "Whilst the advances in knowledge about CVD risk factors have been significant, the challenge now is to get people, not just doctors, to understand the impact of these risk factors on their personal risk of a heart attack or stroke. This is where Heart Age is the people-friendly alternative to what doctors have typically used in the clinic environment. It"s a simple idea that presents people"s overall CVD risk as their "Heart Age" compared to their chronological age. This measure of risk better informs people, at all levels of risk, about whether they need to modify or reduce their risk factors and how much effort they should to make to achieve this." At the global media launch, Unilever unveiled a new report entitled "What If People"s Hearts Stayed Young?". It publishes for the first time the theoretical effect on the numbers of heart attacks and strokes (CVD events) over the next decade that might be achieved if people estimated to have an elevated Heart Age were able to reduce it by three years. The modelling used data from the UK and USA as examples. The results are inspiring. They suggest that if people estimated to have elevated Heart Ages lowered them by three years, predicted CVD events could be reduced over ten years by an estimated 216,000 in the UK, and by an estimated 1 million in the USA. The modelling further calculates that, if everyone - not just those with elevated Heart Ages - managed to keep their Heart Age as young as their chronological age, the predicted number of CVD events over ten years could be reduced by an estimated 986,000 in the UK and by an estimated 5 million in the USA. Unilever has built on the concept of Heart Age and developed an accurate and simple online tool to enable people to find out their own Heart Age and for health professionals to better engage their patients in their own heart health. After piloting the Heart Age Tool in 18 countries, Unilever has developed it further, adding a tailored heart health plan to guide and motivate people to make lifelong changes to their diet and lifestyle that can help reduce their personal cardiovascular disease risk factors. Unilever"s Chief Executive Officer, Paul Polman, says the company will track and share information on progress by publishing data at regular intervals for the benefit of the wider heart health community. Over 2 million people have taken the Heart Age test to date. This has given Unilever the confidence to focus its heart health consumer awareness and education efforts on a specific goal - to motivate 100 million people worldwide to take the Heart Age test and to encourage diet and lifestyle changes to lower elevated Heart Ages in this group by three years, on average, by 2020. Notes - According to the World Health Organization (WHO), deaths from CVD will increase from 17.2 million per year in 2005 to 24 million per year in 2030 - the equivalent of losing more than the entire population of Australia every year - The Heart Age concept is a translation of the well established Framingham Risk Score, which has been adapted into similar European risk assessment scores - Heart Age is about the "relative risk" of a person developing CVD over the next ten years, compared to a healthy person. This relative risk is virtually the same whichever risk score is used - Heart Age is a simple way of estimating and expressing common cardiovascular risk factors. The Heart Age tool does not provide diagnostic information, does not evaluate an individual"s medical condition, and does not provide medical advice. People should consult their doctor for medical information and advice - The Heart Age Tool was developed by Unilever and builds upon the output of a research project published in the peer-reviewed journal, Circulation - EUROPREV is the European Network for Prevention and Health Promotion in Family Medicine and General Practice and was launched after the 1st International Meeting on Prevention and Health Promotion in Europe, which took place in November, 1995 - Take the Heart Age test for yourself at www.heartagecalculator.com This is a generic holding page that allows you to access the new global website if you wish to remind yourself of the new-look Heart Age Tool, as presented at the global media launch on Tuesday June 9, 2009 Find the Heart Age Tool here http://www.heartagecalculator.com About Unilever Unilever"s mission is to add vitality to life. We meet everyday needs for nutrition, hygiene and personal care with brands that help people feel good, look good and get more out of life. Unilever is one of the world"s leading suppliers of fast moving consumer goods with strong local roots in more than 100 countries across the globe. Its portfolio includes some of the world"s best known and most loved brands including thirteen €1 billion brands and global leadership in many categories in which the company operates. About the World Heart Federation The World Heart Federation is a non-governmental organization based in Geneva, Switzerland dedicated to the prevention and control of heart disease and stroke, with a focus on low- and middle-income countries. It comprises 198 member societies of cardiology and heart foundations from over 100 countries, covering the regions of Asia-Pacific, Europe, East Mediterranean, the Americas and Africa. For further information visit http://www.worldheart.org World Heart Federation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009